Effects of Refinery Processes on the Quality of Various Water Samples from Kaduna Refinery and Petrochemical Company (KRPC) Limited

Effects of refinery processes on the quality of various water samples from Kaduna Refinery and Petrochemical Company (KRPC) Limited was investigated. Water quality assessment was carried out on samples collected at different water treatment sampling points in the refinery. The physicochemical parameters and other forms of analytical processes used in the work were of the standards of American Standards of Testing Materials (ASTM) and American Public Health Association (APHA) using spectrophotometric and volumetric methods. Results obtained showed that the quality of water samples subjected to treatment at each water treatment section in KRPC during the course of study was acceptable from physico-chemical parameters assessed and may not be injurious to the boiler and its other end uses. Also, result of the pre and post refinery operations on cooling water sample assessed showed the significant effect the refinery operation had on the cooling water

Severe generalised hypersensitivity reaction to topical neomycin after cataract surgery: a case report

<p>Abstract</p> <p>Introduction</p> <p>Systemic hypersensitivity reactions to topical ophthalmic treatment occur rarely, but when they do they can be severe as highlighted by this case.</p> <p>Case presentation</p> <p>A post-operative cataract surgery patient developed a severe and generalised hypersensitivity reaction following topical treatment with Maxitrol (Dexamethasone and Neomycin) eye drops. The patient reported a previous allergic reaction to Neomycin.</p> <p>Conclusion</p> <p>This case report emphasises the importance of a thorough drug and allergy history when patients are seen at pre-assessment or clerked in for surgery.</p

Knowledge, perception and willingness to receive the current COVID-19 vaccine among residents of Awka metropolis, Anambra State, Nigeria

Background: Vaccines can effectively reduce most morbidities and mortalities caused by infectious agents. The emergence of the COVID-19 vaccine may be accompanied with huge success in containing the pandemic. The aim of the study was to assesses knowledge, perception and willingness to receive the current COVID-19 vaccine among residents in Awka metropolis, Anambra State, Nigeria.Methods: Using a pre-tested semi-structured questionnaire, this study was conducted in Awka metropolis Anambra State, Nigeria among 393 respondents (aged 18 years and above), and analyzed to assess their knowledge, perception and willingness to receive the current COVID-19 vaccine. Statistical package for social sciences software (SPSS) version 23.0 was used, descriptive statistics were reported in frequencies and percentages, Chi-square test was used to assess the association between socio-demographic characteristics and willingness to receive the vaccine, and level of significance was set at p<0.05.Results: The results showed that all respondents (100%) have good knowledge of the vaccine availability. Only 25.7% were willing to receive the vaccine, although 57.3% were willing to receive any other vaccine apart from the COVID-19 vaccine. Very few respondents (18.3%) thinks the vaccine is accessible to all. Most of the respondents (72%) did not support mandatory implementation of COVID-19 vaccine in Nigeria. Among the socio-demographic characteristics, only occupation was significantly associated with willingness to receive the vaccine (p=0.010, χ2=20.214).  Conclusions: This study highlighted the need to effectively educate the masses through appropriate public health literacy programs and enlightenment campaigns on the role of the vaccine in curbing this pandemic

Transmission risk of respiratory viruses in natural and mechanical ventilation environments: implications for SARS-CoV-2 transmission in Africa.

Respiratory viruses can be transmitted through contact, droplet and airborne routes. Viruses that are not naturally airborne may be aerosolised during medical procedures and transmitted to healthcare workers. Most resource-limited healthcare settings lack complex air handling systems to filter air and create pressure gradients that are necessary for minimising viral transmission. This review explores the association between ventilation and the transmission of respiratory viruses like SAR-CoV-2. When used appropriately, both natural and mechanical ventilation can decrease the concentration of viral aerosols, thereby reducing transmission. Although mechanical ventilation systems are more efficient, installation and maintenance costs limit their use in resource-limited settings, whereas the prevailing climate conditions make natural ventilation less desirable. Cost-effective hybrid systems of natural and mechanical ventilation may overcome these limitations

Design and Performance Evaluation of Horizontal- Shaft Palm Kernel Cracking Machine

The need to support the small and medium scale industries involved in palm kernels, led to the design, fabrication and evaluation of a horizontal shaft palm kernel cracking machine. All the materials were sourced locally in Nigeria which makes it affordable for small and medium scale farmers involved with palm kernel. The basic features of the machine include a horizontal shaft, hopper, cracking chamber, pulleys, bearings with housing, discharge outlet and electric motor (prime mover). The mean efficiency of the machine under good operating conditions is 75.5%. The production cost of the machine excluding electric motor was estimated to be one hundred and fifty-one dollar forty-sixcents (US$151.46), based on the exchange rate when it was manufactured. The cost can further be reduced, if mass-produced

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Respiratory mucosal immunity induced by vaccination is vital for protection from coronavirus infection in animal models. In humans, the capacity of peripheral vaccination to generate sustained immunity in the lung mucosa, and how this is influenced by prior SARS-CoV-2 infection, is unknown. Here we show using bronchoalveolar lavage samples that donors with history of both infection and vaccination have more airway mucosal SARS-CoV-2 antibodies and memory B cells than those only vaccinated. Infection also induces populations of airway spike-specific memory CD4+ and CD8+ T cells that are not expanded by vaccination alone. Airway mucosal T cells induced by infection have a distinct hierarchy of antigen specificity compared to the periphery. Spike-specific T cells persist in the lung mucosa for 7 months after the last immunising event. Thus, peripheral vaccination alone does not appear to induce durable lung mucosal immunity against SARS-CoV-2, supporting an argument for the need for vaccines targeting the airways

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Respiratory mucosal immunity induced by vaccination is vital for protection from coronavirus infection in animal models. In humans, the capacity of peripheral vaccination to generate sustained immunity in the lung mucosa, and how this is influenced by prior SARS-CoV-2 infection, is unknown. Here we show using bronchoalveolar lavage samples that donors with history of both infection and vaccination have more airway mucosal SARS-CoV-2 antibodies and memory B cells than those only vaccinated. Infection also induces populations of airway spike-specific memory CD4+ and CD8+ T cells that are not expanded by vaccination alone. Airway mucosal T cells induced by infection have a distinct hierarchy of antigen specificity compared to the periphery. Spike-specific T cells persist in the lung mucosa for 7 months after the last immunising event. Thus, peripheral vaccination alone does not appear to induce durable lung mucosal immunity against SARS-CoV-2, supporting an argument for the need for vaccines targeting the airways

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Respiratory mucosal immunity induced by vaccination is vital for protection from coronavirus infection in animal models. In humans, the capacity of peripheral vaccination to generate sustained immunity in the lung mucosa, and how this is influenced by prior SARS-CoV-2 infection, is unknown. Here we show using bronchoalveolar lavage samples that donors with history of both infection and vaccination have more airway mucosal SARS-CoV-2 antibodies and memory B cells than those only vaccinated. Infection also induces populations of airway spike-specific memory CD4+ and CD8+ T cells that are not expanded by vaccination alone. Airway mucosal T cells induced by infection have a distinct hierarchy of antigen specificity compared to the periphery. Spike-specific T cells persist in the lung mucosa for 7 months after the last immunising event. Thus, peripheral vaccination alone does not appear to induce durable lung mucosal immunity against SARS-CoV-2, supporting an argument for the need for vaccines targeting the airways

Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: A systematic analysis from the Global Burden of Disease Study 2019

Background: Chewing tobacco and other types of smokeless tobacco use have had less attention from the global health community than smoked tobacco use. However, the practice is popular in many parts of the world and has been linked to several adverse health outcomes. Understanding trends in prevalence with age, over time, and by location and sex is important for policy setting and in relation to monitoring and assessing commitment to the WHO Framework Convention on Tobacco Control. Methods: We estimated prevalence of chewing tobacco use as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 using a modelling strategy that used information on multiple types of smokeless tobacco products. We generated a time series of prevalence of chewing tobacco use among individuals aged 15 years and older from 1990 to 2019 in 204 countries and territories, including age-sex specific estimates. We also compared these trends to those of smoked tobacco over the same time period. Findings: In 2019, 273·9 million (95% uncertainty interval 258·5 to 290·9) people aged 15 years and older used chewing tobacco, and the global age-standardised prevalence of chewing tobacco use was 4·72% (4·46 to 5·01). 228·2 million (213·6 to 244·7; 83·29% [82·15 to 84·42]) chewing tobacco users lived in the south Asia region. Prevalence among young people aged 15–19 years was over 10% in seven locations in 2019. Although global age-standardised prevalence of smoking tobacco use decreased significantly between 1990 and 2019 (annualised rate of change: –1·21% [–1·26 to –1·16]), similar progress was not observed for chewing tobacco (0·46% [0·13 to 0·79]). Among the 12 highest prevalence countries (Bangladesh, Bhutan, Cambodia, India, Madagascar, Marshall Islands, Myanmar, Nepal, Pakistan, Palau, Sri Lanka, and Yemen), only Yemen had a significant decrease in the prevalence of chewing tobacco use, which was among males between 1990 and 2019 (−0·94% [–1·72 to –0·14]), compared with nine of 12 countries that had significant decreases in the prevalence of smoking tobacco. Among females, none of these 12 countries had significant decreases in prevalence of chewing tobacco use, whereas seven of 12 countries had a significant decrease in the prevalence of tobacco smoking use for the period. Interpretation: Chewing tobacco remains a substantial public health problem in several regions of the world, and predominantly in south Asia. We found little change in the prevalence of chewing tobacco use between 1990 and 2019, and that control efforts have had much larger effects on the prevalence of smoking tobacco use than on chewing tobacco use in some countries. Mitigating the health effects of chewing tobacco requires stronger regulations and policies that specifically target use of chewing tobacco, especially in countries with high prevalence. Funding: Bloomberg Philanthropies and the Bill & Melinda Gates Foundation